from Global Health Program

Health-care Provision and Health-care Reform in Post-Mao China

April 03, 2014

Testimony
Testimony by CFR fellows and experts before Congress.

More on:

China

Health

An effective strategy to engage China's health-care sector requires the U.S. government to continue promoting business opportunities for U.S. biopharmaceutical firms, hospital groups, and insurance companies, CFR Senior Fellow for Global Health Yanzhong Huang tells the U.S.-China Economic and Security Review Commission. In the meantime, it is also important for the U.S. government and companies to demonstrate the willingness to work with China in addressing health issues of their immediate concern.

More on:

China

Health

Top Stories on CFR

Oil and Petroleum Products

Western leaders have long criticized OPEC’s power to raise oil prices, but the bloc’s influence is on the wane as U.S. oil production has soared and alternative energies have come to the fore.

Russia

A move to block sanctions relief has been defeated, averting a likely spike in global aluminum prices but also spotlighting the tough road ahead for Congress in shaping policy on Russia.

United Kingdom

Brexit supporters argue that the EU threatens sovereignty and stifles growth, while opponents counter that EU membership strengthens trade, investment, and the UK’s standing in the world.